Sung-gyun Ahn

Wondu, KR 
Wondu, KR 

Overview

Sung-gyun Ahn practices practicing medicine in Wondu, Republic of Korea.

Their clinical expertise encompasses Coronary Heart Disease, Heart Attack, Hereditary Paraganglioma-Pheochromocytoma Syndrome, Necrosis, and Percutaneous Coronary Intervention (PCI).

They are actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 3 clinical trials.

Locations

Wondu, Republic of Korea
Other Locations
Ulsan, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery
Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery
Enrollment Status: Completed
Publish Date: November 05, 2024
Intervention Type: Drug
Study Phase: Phase 4
Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of GENOSS Sirolimus-eluting Stent in Patients With Coronary Artery Disease (GENOSS Registry)
Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of GENOSS Sirolimus-eluting Stent in Patients With Coronary Artery Disease (GENOSS Registry)
Enrollment Status: Completed
Publish Date: January 30, 2023
Intervention Type: Device
Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of Biofreedom Stent in Patients With Coronary Artery Disease (Biofreedom Registry)
Prospective Multicenter Observational Study for Evaluating Efficacy and Safety of Biofreedom Stent in Patients With Coronary Artery Disease (Biofreedom Registry)
Enrollment Status: Terminated
Publish Date: May 13, 2021
Intervention Type: Device
View 2 Less Clinical Trials

11 Total Publications

Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial.
Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial.
Journal: Lipids
Published: December 18, 2024

Frequently Asked Questions about Sung-gyun Ahn

Is Sung-gyun Ahn a top-rated expert for Coronary Heart Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Sung-gyun Ahn is classified as an Experienced expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sung-gyun Ahn participate in research or clinical trials?

Yes. Sung-gyun Ahn has published 11 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Sung-gyun Ahn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ahn's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile